Galectin-1, mainly expressed in activated pancreatic stellate cells (PSCs), is involved in many important cancer-related processes. However, very little is known how Galectin-1 modulates PSCs and subsequently impacts pancreatic cancer cells (PCCs). Our chemokine antibody array and in vitro studies demonstrates that Galectin-1 induces secretion of stromal cell-derived factor-1(SDF-1) in PSCs by activating NF-κB signaling. The secreted SDF-1 increases migration and invasion of PCCs. Knockdown of Galectin-1 and inhibitor-mediated blockade of SDF-1 as well as its ligand CXCR4 and NF-κB verifies the findings. In vivo experiment by knockdown of Galectin-1 in PSCs further demonstrates the conclusion. Collectively, the present studies demonstrate that Galectin-1-driven production of SDF-1 in PSCs through activation of NF-κB promotes metastasis in PDAC, offering a potential target in the treatment of pancreatic cancer.
Credits:
Dong Quiana,b,f, Zipeng Lua,b, Quingcheng Xua,b,g, Pengfei Wua,b, Lei Tiana,b, Liangtao Zhaoa,b, Baobao Caia,b, Jie Yina,b, Yang Wua,b, Kevin F. Staveley-O’Carrolc,d,e, Kuirong Jianga,b, Miao Yia,b, Guangfu Lic,d
- a. Pancreas Center, the First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China
- b. Pancreas Institute, Nanjing Medical University, Nanjing 210029, China
- c. Department of Surgery, University of Missouri, Columbia, MO 65212, USA
- d. Ellis Fischel Cancer Center, University of Missouri, Columbia, MO 65212, USA
- e. Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65212, USA
- f. Department of General surgery, Affiliated Hospital of Nanjing University of TCM, Jiangsu Province Hospital of TCM, Nanjing 210029, China
- g. Department of Gastroenterology, Subei Pople’s Hospital, Clinical Medical School, Yangzhou University Affiliated Hospital, Yangzhou 225000, China
SIÈGE SOCIAL
Parc d'activités Activestre
31390 Carbonne - FRANCE
CONTACT
Tél. +33 561 971 974
Fax +33 561 971 975